Mielóma multiplex: vizsgálatok itt: Izrael
35 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 60
- Run by
- Hadassah Medical Organization
See details and how to joinNCT07333430 - No phaseTaking peopleEarly Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Tel Aviv
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704 - No phaseTaking peopleIntegrative Therapies in Multiple Myeloma
- Where
- Haifa
- Életkor
- 18 év and over
- People
- 300
- Run by
- Bnai Zion Medical Center
See details and how to joinNCT06515249 - 3. fázisTaking peopleA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Ashdod, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186 - No phaseBefejeződöttA Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
- Where
- Jerusalem, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Janssen-Cilag Ltd.
See details and how to joinNCT06285318 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Beersheba, Jerusalem, Ramat Gan
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839 · EU 2022-501941-63-00 - No phaseTaking peoplePredicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
- Where
- Beersheba, Haifa, Petah Tikva, Tel Aviv
- Életkor
- 30 év and over
- People
- 2000
- Run by
- Tel-Aviv Sourasky Medical Center
See details and how to joinNCT05837884 - 3. fázisTaking peopleA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Beersheba, Jerusalem, Koranit, Petah Tikva, Tel Aviv
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - 1. fázisTaking peopleA Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
- Where
- Haifa, Jerusalem, Tel Aviv
- Életkor
- 18 év and over
- People
- 87 worldwide
- Run by
- Sanofi
See details and how to joinNCT06630806 - 1/2. fázisTaking peopleStudy of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 75
- Run by
- Sheba Medical Center
See details and how to joinNCT05243212